The clinical reference laboratory market size has grown strongly in recent years. It will grow from $47 billion in 2025 to $50.24 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to chronic disease prevalence, hospital diagnostic outsourcing, infectious disease testing demand, regulatory compliance needs, laboratory consolidation.
The clinical reference laboratory market size is expected to see strong growth in the next few years. It will grow to $64.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to genomic testing expansion, AI-based diagnostics adoption, personalized medicine growth, healthcare digitization, population health screening demand. Major trends in the forecast period include expansion of molecular diagnostics, automation of laboratory testing, growth of high-complexity testing, demand for rapid diagnostic turnaround, centralization of diagnostic services.
The growing demand for diagnostic testing is expected to drive the expansion of the clinical reference laboratory market in the future. Diagnostic testing involves analyzing biological samples to detect, diagnose, and monitor diseases, medical conditions, or infections. This surge in demand for diagnostic testing is largely due to advancements in medical technology, which have made tests more accessible, accurate, and efficient. Clinical reference laboratories play a crucial role in diagnostic testing, offering specialized and precise analysis through advanced technologies and standardized protocols. These laboratories ensure reliable test results that are critical for early disease detection, treatment planning, and patient monitoring across a variety of medical fields. For example, in April 2024, a report from the National Health Service (NHS), the UK’s publicly funded healthcare system, revealed that 376,200 patients were waiting over six weeks for a key diagnostic test, marking an increase of 21,200 from the previous month. As a result, the growing demand for diagnostic testing is expected to drive the clinical reference laboratory market’s growth.
Key players in the clinical reference laboratory market are focusing on developing advanced products, such as automated sample processing platforms, to improve efficiency, accuracy, and scalability. Automated sample processing platforms are high-throughput laboratory systems that use robotics and advanced software to handle, prepare, and analyze biological samples with minimal human intervention, ensuring efficiency, accuracy, and standardization in diagnostic and research workflows. For example, in January 2023, QIAGEN NV, a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the EZ2 Connect MDx platform for diagnostic laboratories. The EZ2 Connect MDx is an IVD platform designed for automated sample processing, allowing laboratories to efficiently purify DNA and RNA from 24 samples simultaneously in as little as 30 minutes. It utilizes magnetic-bead technology for nucleic acid extraction from various sample types, including blood plasma, serum, and stool. The platform is equipped with prefilled, sealed reagent cartridges, integrated cameras for load checking, and UV decontamination features to ensure process safety and reduce contamination risks. Additionally, it includes onboard pipetting, heating, and automated piercing of sealed cartridges for seamless operation. The resulting analyte is compatible with multiple downstream technologies, such as real-time PCR, digital PCR, and next-generation sequencing.
In April 2024, Eurofins Scientific, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed amount. This acquisition enables Eurofins Scientific to enhance its presence in renal and transplant testing by integrating Ascend Clinical's expertise, advanced laboratory services, and established client base with Eurofins’ extensive network, technological capabilities, and industry relationships. This merger is expected to improve diagnostic offerings, enhance patient care, and drive growth in the clinical diagnostics sector across the United States. Ascend Clinical LLC is a U.S.-based provider of clinical reference laboratory testing and services.
Major companies operating in the clinical reference laboratory market are Mayo Clinic Laboratories, Eurofins Scientific, Quest Diagnostics, Sonic Healthcare, Unilabs, ARUP Laboratories, Lancet Laboratories, NeoGenomics Laboratories, Ampath Laboratories, Clinical Reference Laboratory, Al Borg Medical Laboratories, Medsol Diagnostics, Medlabs Group, Cerba International, Lifebrain Group, CRL Diagnostics, Dr. Lal PathLabs, SRL Diagnostics, Synlab International, ACM Global Laboratories, Laboratory Corporation of America (Labcorp), KingMed Diagnostics.
North America was the largest region in the clinical reference laboratory market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical reference laboratory market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical reference laboratory market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of reagents, diagnostic instruments, and automated testing platforms, affecting molecular diagnostics and genetics testing. Asia-Pacific and North America are most impacted. However, tariffs are driving local reagent production and laboratory automation investments.
The clinical reference laboratory market research report is one of a series of new reports that provides clinical reference laboratory market statistics, including clinical reference laboratory industry global market size, regional shares, competitors with a clinical reference laboratory market share, detailed clinical reference laboratory market segments, market trends and opportunities, and any further data you may need to thrive in the clinical reference laboratory industry. This clinical reference laboratory market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A clinical reference laboratory is a specialized facility that conducts high-complexity diagnostic testing and analysis on biological samples, including blood, urine, and tissue. These labs provide advanced testing services such as molecular diagnostics, toxicology, immunology, and pathology. They are equipped with cutting-edge technology and follow strict regulatory standards to ensure the accuracy, reliability, and compliance of their results with healthcare regulations.
The main types of clinical reference laboratories include clinical chemistry, genetics testing, microbiology, cytology, and others. Clinical chemistry, a branch of clinical pathology, focuses on the quantitative analysis of bodily fluids such as blood and urine to determine the concentration of various chemical substances. This field employs a range of technologies, from traditional laboratory methods to digital technologies, automated testing platforms, and molecular diagnostics, and is utilized by clinics, hospitals, and independent labs.
The clinical reference laboratory market consists of revenues earned by entities by providing services such as pathology services, biomarker testing and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical reference laboratory market also includes sales of diagnostic test kits, blood collection tubes, microbiology culture media and immunoassay reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The clinical reference laboratory market size is expected to see strong growth in the next few years. It will grow to $64.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to genomic testing expansion, AI-based diagnostics adoption, personalized medicine growth, healthcare digitization, population health screening demand. Major trends in the forecast period include expansion of molecular diagnostics, automation of laboratory testing, growth of high-complexity testing, demand for rapid diagnostic turnaround, centralization of diagnostic services.
The growing demand for diagnostic testing is expected to drive the expansion of the clinical reference laboratory market in the future. Diagnostic testing involves analyzing biological samples to detect, diagnose, and monitor diseases, medical conditions, or infections. This surge in demand for diagnostic testing is largely due to advancements in medical technology, which have made tests more accessible, accurate, and efficient. Clinical reference laboratories play a crucial role in diagnostic testing, offering specialized and precise analysis through advanced technologies and standardized protocols. These laboratories ensure reliable test results that are critical for early disease detection, treatment planning, and patient monitoring across a variety of medical fields. For example, in April 2024, a report from the National Health Service (NHS), the UK’s publicly funded healthcare system, revealed that 376,200 patients were waiting over six weeks for a key diagnostic test, marking an increase of 21,200 from the previous month. As a result, the growing demand for diagnostic testing is expected to drive the clinical reference laboratory market’s growth.
Key players in the clinical reference laboratory market are focusing on developing advanced products, such as automated sample processing platforms, to improve efficiency, accuracy, and scalability. Automated sample processing platforms are high-throughput laboratory systems that use robotics and advanced software to handle, prepare, and analyze biological samples with minimal human intervention, ensuring efficiency, accuracy, and standardization in diagnostic and research workflows. For example, in January 2023, QIAGEN NV, a Germany-based provider of sample and assay technologies for molecular diagnostics, launched the EZ2 Connect MDx platform for diagnostic laboratories. The EZ2 Connect MDx is an IVD platform designed for automated sample processing, allowing laboratories to efficiently purify DNA and RNA from 24 samples simultaneously in as little as 30 minutes. It utilizes magnetic-bead technology for nucleic acid extraction from various sample types, including blood plasma, serum, and stool. The platform is equipped with prefilled, sealed reagent cartridges, integrated cameras for load checking, and UV decontamination features to ensure process safety and reduce contamination risks. Additionally, it includes onboard pipetting, heating, and automated piercing of sealed cartridges for seamless operation. The resulting analyte is compatible with multiple downstream technologies, such as real-time PCR, digital PCR, and next-generation sequencing.
In April 2024, Eurofins Scientific, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed amount. This acquisition enables Eurofins Scientific to enhance its presence in renal and transplant testing by integrating Ascend Clinical's expertise, advanced laboratory services, and established client base with Eurofins’ extensive network, technological capabilities, and industry relationships. This merger is expected to improve diagnostic offerings, enhance patient care, and drive growth in the clinical diagnostics sector across the United States. Ascend Clinical LLC is a U.S.-based provider of clinical reference laboratory testing and services.
Major companies operating in the clinical reference laboratory market are Mayo Clinic Laboratories, Eurofins Scientific, Quest Diagnostics, Sonic Healthcare, Unilabs, ARUP Laboratories, Lancet Laboratories, NeoGenomics Laboratories, Ampath Laboratories, Clinical Reference Laboratory, Al Borg Medical Laboratories, Medsol Diagnostics, Medlabs Group, Cerba International, Lifebrain Group, CRL Diagnostics, Dr. Lal PathLabs, SRL Diagnostics, Synlab International, ACM Global Laboratories, Laboratory Corporation of America (Labcorp), KingMed Diagnostics.
North America was the largest region in the clinical reference laboratory market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical reference laboratory market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical reference laboratory market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased costs of reagents, diagnostic instruments, and automated testing platforms, affecting molecular diagnostics and genetics testing. Asia-Pacific and North America are most impacted. However, tariffs are driving local reagent production and laboratory automation investments.
The clinical reference laboratory market research report is one of a series of new reports that provides clinical reference laboratory market statistics, including clinical reference laboratory industry global market size, regional shares, competitors with a clinical reference laboratory market share, detailed clinical reference laboratory market segments, market trends and opportunities, and any further data you may need to thrive in the clinical reference laboratory industry. This clinical reference laboratory market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A clinical reference laboratory is a specialized facility that conducts high-complexity diagnostic testing and analysis on biological samples, including blood, urine, and tissue. These labs provide advanced testing services such as molecular diagnostics, toxicology, immunology, and pathology. They are equipped with cutting-edge technology and follow strict regulatory standards to ensure the accuracy, reliability, and compliance of their results with healthcare regulations.
The main types of clinical reference laboratories include clinical chemistry, genetics testing, microbiology, cytology, and others. Clinical chemistry, a branch of clinical pathology, focuses on the quantitative analysis of bodily fluids such as blood and urine to determine the concentration of various chemical substances. This field employs a range of technologies, from traditional laboratory methods to digital technologies, automated testing platforms, and molecular diagnostics, and is utilized by clinics, hospitals, and independent labs.
The clinical reference laboratory market consists of revenues earned by entities by providing services such as pathology services, biomarker testing and pharmacogenomics. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical reference laboratory market also includes sales of diagnostic test kits, blood collection tubes, microbiology culture media and immunoassay reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Clinical Reference Laboratory Market Characteristics
3. Clinical Reference Laboratory Market Supply Chain Analysis
4. Global Clinical Reference Laboratory Market Trends and Strategies
5. Clinical Reference Laboratory Market Analysis of End Use Industries
7. Global Clinical Reference Laboratory Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Clinical Reference Laboratory Total Addressable Market (TAM) Analysis for the Market
9. Clinical Reference Laboratory Market Segmentation
10. Clinical Reference Laboratory Market Regional and Country Analysis
11. Asia-Pacific Clinical Reference Laboratory Market
12. China Clinical Reference Laboratory Market
13. India Clinical Reference Laboratory Market
14. Japan Clinical Reference Laboratory Market
15. Australia Clinical Reference Laboratory Market
16. Indonesia Clinical Reference Laboratory Market
17. South Korea Clinical Reference Laboratory Market
18. Taiwan Clinical Reference Laboratory Market
19. South East Asia Clinical Reference Laboratory Market
20. Western Europe Clinical Reference Laboratory Market
21. UK Clinical Reference Laboratory Market
22. Germany Clinical Reference Laboratory Market
23. France Clinical Reference Laboratory Market
24. Italy Clinical Reference Laboratory Market
25. Spain Clinical Reference Laboratory Market
26. Eastern Europe Clinical Reference Laboratory Market
27. Russia Clinical Reference Laboratory Market
28. North America Clinical Reference Laboratory Market
29. USA Clinical Reference Laboratory Market
30. Canada Clinical Reference Laboratory Market
31. South America Clinical Reference Laboratory Market
32. Brazil Clinical Reference Laboratory Market
33. Middle East Clinical Reference Laboratory Market
34. Africa Clinical Reference Laboratory Market
36. Clinical Reference Laboratory Market Competitive Landscape and Company Profiles
37. Clinical Reference Laboratory Market Other Major and Innovative Companies
40. Clinical Reference Laboratory Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Clinical Reference Laboratory Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses clinical reference laboratory market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for clinical reference laboratory? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical reference laboratory market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Clinical Chemistry; Genetics Testing; Microbiology And Cytology; Other Types2) By Technology: Traditional Laboratory Techniques; Digital Technologies; Automated Testing Platforms; Molecular Diagnostics
3) By Application: Clinics; Hospitals; Independent Laboratory
Subsegments:
1) By Clinical Chemistry: Blood Gas Analysis; Enzyme Testing; Electrolyte Testing; Lipid Panel; Liver Function Testing; Renal Function Testing2) By Genetics Testing: Carrier Screening; Diagnostic Testing; Predictive And Presymptomatic Testing; Pharmacogenomics; Prenatal And Newborn Testing
3) By Microbiology And Cytology: Bacterial Culture Testing; Fungal Culture Testing; Viral Testing; Parasitology Testing; Cytopathology
4) By Other Types: Immunology Testing; Hematology Testing; Toxicology Testing; Endocrinology Testing
Companies Mentioned: Mayo Clinic Laboratories; Eurofins Scientific; Quest Diagnostics; Sonic Healthcare; Unilabs; ARUP Laboratories; Lancet Laboratories; NeoGenomics Laboratories; Ampath Laboratories; Clinical Reference Laboratory; Al Borg Medical Laboratories; Medsol Diagnostics; Medlabs Group; Cerba International; Lifebrain Group; CRL Diagnostics; Dr. Lal PathLabs; SRL Diagnostics; Synlab International; ACM Global Laboratories; Laboratory Corporation of America (Labcorp); KingMed Diagnostics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Clinical Reference Laboratory market report include:- Mayo Clinic Laboratories
- Eurofins Scientific
- Quest Diagnostics
- Sonic Healthcare
- Unilabs
- ARUP Laboratories
- Lancet Laboratories
- NeoGenomics Laboratories
- Ampath Laboratories
- Clinical Reference Laboratory
- Al Borg Medical Laboratories
- Medsol Diagnostics
- Medlabs Group
- Cerba International
- Lifebrain Group
- CRL Diagnostics
- Dr. Lal PathLabs
- SRL Diagnostics
- Synlab International
- ACM Global Laboratories
- Laboratory Corporation of America (Labcorp)
- KingMed Diagnostics
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 50.24 Billion |
| Forecasted Market Value ( USD | $ 64.93 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
